| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $4K | — |
| Cost of Revenue | $4K | — |
| R&D Expense | $13.0M | -3.0% |
| SG&A Expense | $12.4M | -8.1% |
| Operating Income | -$25.4M | +5.6% |
| Interest Expense | $2.4M | +71.9% |
| Net Income | -$27.3M | +2.7% |
| EPS (Basic) | -$0.66 | +20.5% |
| EPS (Diluted) | -$0.66 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.8M | -35.1% |
| Inventory | $110K | — |
| Current Assets | $20.7M | -25.1% |
| Total Assets | $28.8M | -7.3% |
| Current Liabilities | $9.5M | +111.2% |
| Total Liabilities | $19.8M | +43.3% |
| Stockholders' Equity | $9.0M | -47.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.8M | +5.1% |
| Capital Expenditures | $2.8M | +427.0% |
| Investing Cash Flow | -$4.0M | -353.9% |
| Financing Cash Flow | $19.8M | -8.0% |
| Free Cash Flow | -$26.7M | -4.0% |
| +20.5% |